| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |